FOR PRESCRIBERS & CLINICS
Your Specialty Pharmacy Partner for Tardive Dyskinesia & Huntington’s Disease Chorea
At Patriot Pharmacy, we cater to the unique needs of clinics and prescribers. Our specialized support for Austedo® and Ingrezza® is designed to integrate into your care approach, helping the individuals you serve access therapy and stay on track.
Uncontrolled movements from tardive dyskinesia or Huntington’s disease chorea can affect daily function, safety, and quality of life. Specialty pharmacy coordination can reduce delays tied to prior authorization, benefits investigation, and ongoing refill support. Patriot Pharmacy offers personalized specialty pharmacy support so your patients can start and continue therapy with fewer access barriers.
Dependable access. Responsive support for your patients.
Why providers partner with Patriot for Austedo® & Ingrezza®
specialty support:
Stronger therapy continuity
– These are long-term specialty treatments. We help keep starts and refills moving so patients are less likely to miss doses.
Access to hard-to-manage specialty meds
– Getting Austedo® & Ingrezza® in place quickly is important. Our team helps clear the path when your patient is ready to begin or stay on therapy.
Smoother prior authorization support
– Our specialty team helps work through payer requirements and reduce the back-and-forth that slows treatment starts.
Fewer interruptions in care
– We partner with your office to limit coverage delays and keep prescribed therapy on schedule.
Experienced specialty pharmacy staff
– You work with pharmacists and support team members who understand complex specialty workflows and provider communication.
Clear, timely updates
– We keep your office informed on status changes so issues can be resolved before they disrupt care.
Neighborhood-level service
– As an independent North Philadelphia pharmacy, we offer personal, high-touch support instead of call-center runaround.
Learn More
Benefits of Austedo® & Ingrezza® Specialty Pharmacy Support
Every patient should receive respectful, attentive care. As your local specialty pharmacy partner, Patriot Pharmacy collaborates with your care team to help patients start prescribed therapy promptly and remain supported throughout ongoing Austedo and Ingrezza
treatment.
We partner with you to:
- Ease the administrative load on your staff
- Strengthen access to critical specialty medications
- Simplify prior authorization workflows
- Align fulfillment with your patients’ treatment needs
- Reinforce adherence after therapy begins
Specialty Medications for Tardive Dyskinesia & HD Chorea
Patriot Pharmacy supports access to critical and often difficult-to-access specialty medications used in adults with tardive dyskinesia and chorea associated with Huntington’s disease. These medications are oral specialty therapies managed through coordinated pharmacy support.
Austedo® / Austedo XR®
(deutetrabenazine)
A VMAT2 inhibitor FDA-approved in adults for tardive dyskinesia and chorea associated with Huntington’s disease. Available as tablets and once-daily extended-release tablets.
Ingrezza® / Ingrezza® Sprinkle
(valbenazine)
A VMAT2 inhibitor FDA-approved in adults for tardive dyskinesia and chorea associated with Huntington’s disease. Available as capsules and sprinkle capsules.
Both medicines are specialty therapies. Access may require insurance authorization and coordinated fulfillment. For full dosing, administration, and safety details, refer to the official Prescribing Information.
Austedo/Austedo XR and Ingrezza carry serious warnings in people with Huntington’s disease, including risk of depression and suicidal thoughts or actions. Direct clinicians to full Prescribing Information, including Boxed Warning language, before prescribing decisions.
Expert Care and Support for Complex Medication Needs
Explore Our Specialty Pharmacy Services
From prior authorizations to personalized counseling, Patriot Pharmacy’s specialty services are built to support patients with chronic or complex conditions. Our streamlined process, clinical expertise, and ACHC-accredited standards help make specialty medications easier to manage for both patients and providers.
References
U.S. Food and Drug Administration. (2025). AUSTEDO XR (deutetrabenazine) extended-release tablets and AUSTEDO (deutetrabenazine) tablets, for oral use [Prescribing information]. Retrieved July 24, 2026, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/208082s018,216354s008lbl.pdf
U.S. Food and Drug Administration. (2025). INGREZZA (valbenazine) capsules, for oral use [Prescribing information]. Retrieved July 24, 2026, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209241s029lbl.pdf
U.S. Food and Drug Administration. (2023). AUSTEDO XR (deutetrabenazine) extended-release tablets and AUSTEDO (deutetrabenazine) tablets, for oral use [Prescribing information]. Retrieved July 24, 2026, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216354s000lbl.pdf
National Institute of Neurological Disorders and Stroke. (n.d.). Huntington’s disease. National Institutes of Health. Retrieved July 24, 2026, from https://www.ninds.nih.gov/health-information/disorders/huntingtons-disease
MedlinePlus. (n.d.). Tardive dyskinesia. National Library of Medicine. Retrieved July 24, 2026, from https://medlineplus.gov/ency/article/000685.htm
MedlinePlus. (n.d.). Huntington disease. National Library of Medicine. Retrieved July 24, 2026, from https://medlineplus.gov/ency/article/000770.htm
MedlinePlus Genetics. (n.d.). Huntington’s disease. National Library of Medicine. Retrieved July 24, 2026, from https://medlineplus.gov/genetics/condition/huntingtons-disease/
Teva Pharmaceuticals. (n.d.). AUSTEDO® / AUSTEDO XR® (deutetrabenazine). Retrieved July 24, 2026, from https://www.austedo.com/
Neurocrine Biosciences. (n.d.). INGREZZA® (valbenazine) capsules. Retrieved July 24, 2026, from https://www.ingrezza.com/
Huntington’s Disease Society of America. (n.d.). Huntington’s Disease Society of America. Retrieved July 24, 2026, from https://hdsa.org/
